The control of the blood glucose levels within acceptable ranges is key in the management of these health issues that causes 1 death every 8 seconds.Today's glucose monitoring devices (GMD) are turning from painful and invasive methods to minimally invasive or none-invasive. Our method for easy and pain-free continuous blood glucose measurement would be revolutionary in the treatment of diabetes and life changing for diabetic patients worldwide.
WITO will be the first continuous glucose monitoring wearable (smartwatch) based on bio-impedance working principles and certified as Medical Device Class IIb. it is the result of the integration of our proprietary bio-impedance measuring chip, a Machine Learning based algorithm that correlates electrical signals with blood ,glucose levels reinforced by heart rate variability and body temperature parameters, watch embedded electrodes.
The customers of our solution will be a diverse group such as the end-user´s themselves, private hospitals, health insurance companies, public health services, social services, among others.
Videos
Additional Info
Sponsorship Level
StartUp